EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Intergenic Type LncRNA (LINC RNA) Faces in Cancer with In Silico Scope and a Directed Lens to LINC00511: A Step toward ncRNA Precision

Shorouk Eldash iD, Eman F Sanad iD, Dina Nada, Nadia M Hamdy iD

Non-Coding RNA · 25.09.2023 · 9 (5) · 58

DOI: 10.3390/ncrna9050058 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Non-Coding RNA, online erschienen am 25.09.2023. Verfasst von Shorouk Eldash und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology and Biochemistry Department, Faculty of Pharmacy, The British University in Egypt (BUE), El Sherouk, Cairo 11837, Egypt. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Long intergenic non-coding RNA, is one type of lncRNA, exerting various cellular activities, as does ncRNA, including the regulation of gene expression and chromatin remodeling. The abnormal expression of lincRNAs can induce or suppress carcinogenesis. Main body: LincRNAs can regulate cancer progression through different mechanisms and are considered as potential drug targets. Genetic variations such as single nucleotide polymorphisms (SNPs) in lincRNAs may affect gene expression and messenger ribonucleic acid (mRNA) stability. SNPs in lincRNAs have been found to be associated with different types of cancer, as well. Specifically, LINC00511 has been known to promote the progression of multiple malignancies such as breast cancer, colorectal cancer, lung cancer, hepatocellular carcinoma, and others, making it a promising cancer prognostic molecular marker.

Conclusion

LincRNAs have been proved to be associated with different cancer types through various pathways. Herein, we performed a comprehensive literature and in silico databases search listing lncRNAs, lincRNAs including LINC00511, lncRNAs’ SNPs, as well as LINC00511 SNPs in different cancer types, focusing on their role in various cancer types and mechanism(s) of action.

Schlagwörter

Stichwörter der Autor:innen

LINC00511SNPscancerin silicolincRNAlncRNAncRNA precisionprognostic molecular markersingle nucleotide polymorphisms

Autor:innen und Institutionen

  • Pharmacology and Biochemistry Department, Faculty of Pharmacy, The British University in Egypt (BUE), El Sherouk, Cairo 11837, Egypt.
  • Biochemistry Department, Faculty of Pharmacy, Ain Shams University, Abassia, Cairo 11566, Egypt.

ORCID-Profile: Shorouk Eldash, Eman F Sanad, Nadia M Hamdy

Zitieren

APA

Eldash, S., Sanad, E. F., Nada, D., & Hamdy, N. M. (2023). The Intergenic Type LncRNA (LINC RNA) Faces in Cancer with In Silico Scope and a Directed Lens to LINC00511: A Step toward ncRNA Precision. Non-Coding RNA, 9(5), 58. https://doi.org/10.3390/ncrna9050058

Vancouver

Eldash S, Sanad EF, Nada D, Hamdy NM. The Intergenic Type LncRNA (LINC RNA) Faces in Cancer with In Silico Scope and a Directed Lens to LINC00511: A Step toward ncRNA Precision. Non-Coding RNA. 2023;9(5):58. doi:10.3390/ncrna9050058

BibTeX
@article{Eldash2023,
  author = {Eldash, Shorouk and Sanad, Eman F and Nada, Dina and Hamdy, Nadia M},
  title = {The Intergenic Type LncRNA (LINC RNA) Faces in Cancer with In Silico Scope and a Directed Lens to LINC00511: A Step toward ncRNA Precision},
  journal = {Non-Coding RNA},
  year = {2023},
  volume = {9},
  number = {5},
  pages = {58},
  doi = {10.3390/ncrna9050058}
}
Kostenlos starten →